1. Anderson LJ, Seward JF. Mumps epidemiology and immunity: the anatomy of a modern epidemic. Pediatr Infect Dis J. 2008. 27:10 Suppl. S75–S79.
2. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet. 2008. 371:932–944.
3. Shulman A, Shohat B, Gillis D, Yavetz H, Homonnai ZT, Paz G. Mumps orchitis among soldiers: frequency, effect on sperm quality, and sperm antibodies. Fertil Steril. 1992. 57:1344–1346.
4. Feldman G, Zer M. Infantile acute pancreatitis after mumps vaccination simulating an acute abdomen. Pediatr Surg Int. 2000. 16:488–489.
5. Singh R, Mostafid H, Hindley RG. Measles, mumps and rubella: the urologist's perspective. Int J Clin Pract. 2006. 60:335–339.
6. Gemmill IM. Mumps vaccine: is it time to re-evaluate our approach? CMAJ. 2006. 175:491–492.
7. Davis NF, McGuire BB, Mahon JA, Smyth AE, O'Malley KJ, Fitzpatrick JM. The increasing incidence of mumps orchitis: a comprehensive review. BJU Int. 2010. 105:1060–1065.
8. Park DW, Nam MH, Kim JY, Kim HJ, Sohn JW, Cho Y, et al. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine. 2007. 25:4665–4670.
9. Ternavasio-de la Vega HG, Boronat M, Ojeda A, Garcia-Delgado Y, Angel-Moreno A, Carranza-Rodriguez C, et al. Mumps orchitis in the post-vaccine era (1967-2009): a single-center series of 67 patients and review of clinical outcome and trends. Medicine (Baltimore). 2010. 89:96–116.
10. Yeniyol CO, Sorguc S, Minareci S, Ayder AR. Role of interferon-alpha-2B in prevention of testicular atrophy with unilateral mumps orchitis. Urology. 2000. 55:931–933.
11. Ku JH, Kim YH, Jeon YS, Lee NK. The preventive effect of systemic treatment with interferon-alpha2B for infertility from mumps orchitis. BJU Int. 1999. 84:839–842.
12. Casella R, Leibundgut B, Lehmann K, Gasser TC. Mumps orchitis: report of a mini-epidemic. J Urol. 1997. 158:2158–2161.
13. Cardenosa N, Dominguez A, Camps N, Martinez A, Torner N, Navas E, et al. Non-preventable mumps outbreaks in schoolchildren in Catalonia. Scand J Infect Dis. 2006. 38:671–674.
14. Castilla J, Garcia Cenoz M, Barricarte A, Irisarri F, Nunez-Cordoba JM, Barricarte A. Mumps outbreak in Navarre region, Spain, 2006-2007. Euro Surveill. 2007. 12:E070215.1.
15. Centers for Disease Control and Prevention (CDC). Mumps epidemic--United kingdom, 2004-2005. MMWR Morb Mortal Wkly Rep. 2006. 55:173–175.
16. Centers for Disease Control and Prevention (CDC). Update: multistate outbreak of mumps--United States, January 1-May 2, 2006. MMWR Morb Mortal Wkly Rep. 2006. 55:559–563.
17. Falk WA, Buchan K, Dow M, Garson JZ, Hill E, Nosal M, et al. The epidemiology of mumps in southern Alberta 1980-1982. Am J Epidemiol. 1989. 130:736–749.
18. Philip J, Selvan D, Desmond AD. Mumps orchitis in the non-immune postpubertal male: a resurgent threat to male fertility? BJU Int. 2006. 97:138–141.
19. Lopez Pacios JC, Parra Muntaner L, Pineiro Fernandez MC, Gomez Cisneros SC, Sanchez Sanchez E, Rivas Escudero JA, et al. Mumps orchitis; review of 8 cases. Arch Esp Urol. 1998. 51:331–333.
20. Candel S. Epididymitis in mumps, including orchitis: further clinical studies and comments. Ann Intern Med. 1951. 34:20–36.
21. Narita M, Matsuzono Y, Takekoshi Y, Yamada S, Itakura O, Kubota M, et al. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G. Clin Diagn Lab Immunol. 1998. 5:799–803.
22. Wu L, Bai Z, Li Y, Rima BK, Afzal MA. Wild type mumps viruses circulating in China establish a new genotype. Vaccine. 1998. 16:281–285.
23. Nojd J, Tecle T, Samuelsson A, Orvell C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine. 2001. 19:1727–1731.
24. Tarantino L, Giorgio A, de Stefano G, Farella N. Echo color Doppler findings in postpubertal mumps epididymo-orchitis. J Ultrasound Med. 2001. 20:1189–1195.
25. Bartak V. Sperm count, morphology and motility after unilateral mumps orchitis. J Reprod Fertil. 1973. 32:491–494.